• About us
• Contact

Advertisement

Organisation › Details

Simris (Group)

Simris Group is a biologics company identifying high value, natural, biologically active compounds found in microalgae and cyanobacteria to extract for applications in skincare, nutrition, and biopharmaceuticals. The company sustainably grows microalgae and cyanobacteria at industrial scale within its photobioreactor facility whereby conditions are optimized for production of these high-value compounds. Simris Group's shares are traded on the Nasdaq First North Growth Market with the short name SIMRIS and ISIN code SE0008091664. *

 

	Start	2023-12-20 existent
	Industry	BIOTECH
	Industry 2	antibody-drug conjugate (ADC)
	Person	Read, Julian (Simris 2023 CEO)
	Region	Sweden_oo
	Country	Sweden
	Street	24A Herrestadsvägen
	City	27650 Hammenhög
	Tel	+46-41-444-5050
		Address record changed: 2023-12-20
Basic data	Employees	n. a.
		* Document for »About Section«: Danforth Advisors, LLC. (1/4/23). "Press Release: Danforth Advisors Acquires Argot Partners". Waltham, MA & New York, NY.
		Record changed: 2024-02-12

Advertisement

More documents for Simris (Group)

• [1] Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.